Who owns Helus Pharma Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HELP from SEC Form 13F filings across 99 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 99 institutions disclosed 29.9M shares of Helus Pharma Inc. worth $197.6M — about 57.1% of shares outstanding; the largest disclosed holder is Venrock Adviser, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
99
13F holders
$197.6M
value, 2026 filers
57.1%
of shares outstanding (29.9M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of HELP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Venrock Adviser, LLC | 3.9M | $25.5M | 0.8% | 7.4% | 0.0% |
| 2 | ORBIMED ADVISORS LLC | 3.3M | $21.6M | 0.4% | 6.3% | -14.6% |
| 3 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.1M | $20.2M | 0.0% | 5.8% | +337.1% |
| 4 | MILLENNIUM MANAGEMENT LLC | 2.6M | $17.4M | 0.0% | 5% | +9.0% |
| 5 | Rosalind Advisors, Inc. | 2.0M | $12.9M | 4.8% | 3.7% | +27.7% |
| 6 | SPHERA FUNDS MANAGEMENT LTD. | 1.6M | $10.7M | 1.4% | 3.1% | +64.2% |
| 7 | ACORN CAPITAL ADVISORS, LLC | 1.5M | $10.2M | 2.8% | 2.9% | 0.0% |
| 8 | DCF Advisers, LLC | 1.4M | $9.5M | 1.7% | 2.7% | +107.4% |
| 9 | Sio Capital Management, LLCNEW | 1.3M | $8.6M | 1.4% | 2.5% | new |
| 10 | Nan Fung Group Holdings Ltd | 987,222 | $6.5M | 5.0% | 1.9% | +114.6% |
| 11 | Boxer Capital Management, LLC | 790,000 | $5.2M | 0.4% | 1.5% | +23.4% |
| 12 | Logos Global Management LPNEW | 750,000 | $5.0M | 0.2% | 1.4% | new |
| 13 | CITADEL ADVISORS LLC | 620,959 | $4.1M | 0.0% | 1.2% | -29.2% |
| 14 | DAFNA Capital Management LLC | 514,061 | $3.4M | 0.6% | 1% | +3.2% |
| 15 | Walleye Capital LLCNEW | 502,554 | $3.3M | 0.0% | 1% | new |
| 16 | MORGAN STANLEY | 461,886 | $3.1M | 0.0% | 0.9% | -55.0% |
| 17 | Knott David M Jr | 370,000 | $2.4M | 1.3% | 0.7% | +5.7% |
| 18 | BANK OF AMERICA CORP /DE/NEW | 337,435 | $2.2M | 0.0% | 0.6% | new |
| 19 | AdvisorShares Investments LLC | 292,711 | $1.9M | 0.2% | 0.6% | +49.6% |
| 20 | JANE STREET GROUP, LLC | 280,903 | $1.9M | 0.0% | 0.5% | +164.1% |
| 21 | JPMORGAN CHASE & CO | 237,828 | $1.6M | 0.0% | 0.5% | +10498.4% |
| 22 | ROYCE & ASSOCIATES LP | 232,078 | $1.5M | 0.0% | 0.4% | +49.7% |
| 23 | UBS Group AG | 218,726 | $1.4M | 0.0% | 0.4% | -8.2% |
| 24 | SUPERSTRING CAPITAL MANAGEMENT LPNEW | 204,424 | $1.4M | 0.9% | 0.4% | new |
| 25 | DIADEMA PARTNERS LPNEW | 200,000 | $1.3M | 0.2% | 0.4% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.